BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• BioAlliance Pharma: Acts in Favour of Patients’ Quality of Life in Connection with the French National Event ‘La Semaine du Goût’

  October 6, 2008

   · 

  1 min read
• Drug Development

  Provectus Pharmaceuticals Inc. Lead Investigator Professor John F. Thompson Gives Update on PV-10 Phase 2 Study

  October 6, 2008

   · 

  1 min read
• Policy

  Celgene Corporation Release: Oral Cancer Drug REVLIMID(R) Receives Marketing Authorization from Health Canada for Treatment of Multiple Myeloma

  October 6, 2008

   · 

  1 min read
• Drug Development

  Unigene Laboratories, Inc. Initiates Phase I Clinical Study for Oral PTH

  October 6, 2008

   · 

  1 min read
• Deals

  Novacea, Inc. and Transcept Pharmaceuticals, Inc. Announce Filing of Form S-4 Proxy/Registration Statement

  October 6, 2008

   · 

  1 min read
• Business

  GeneThera, Inc. Offered World Wide Rights to E.coli Vaccine From the University of New Mexico

  October 6, 2008

   · 

  1 min read
• Policy

  Basilea Pharmaceutica’s Toctino(R) (alitretinoin) Receives Marketing Authorization in Germany

  October 6, 2008

   · 

  1 min read
• Business

  Cegedim SA: 2008 Half-Year Financial Report

  October 6, 2008

   · 

  1 min read
• Pharm Country

  Langer, Inc. Receives NASDAQ Deficiency Letter

  October 6, 2008

   · 

  1 min read
• Pharm Country

  CAS Medical Systems, Inc. Chosen by the Connecticut Technology Council as An Award Winner in the UHY LLP Tech Top 40

  October 6, 2008

   · 

  1 min read